Professor of Toxicology, Ph.D. habil., Senior researcher, Director (em) of the Institute of Toxicology and group leader, University Mainz.

Bernd Kaina obtained his Ph.D. in genetics in 1976 from the University of Halle, Germany. He completed his postdoctoral training at the Institute of Genetics and Plant Breeding in Gatersleben and continued his studies on DNA repair at the Department of Molecular Biology in Leiden, Netherlands, at the German Cancer Research Center in Heidelberg and, as a Heisenberg fellow, at the Department of Genetics of the Nuclear Research Center in Karlsruhe, Germany. In 1993 he was appointed full professor at the Institute of Toxicology of the University of Mainz, Germany, where he was head of an independent research group and, later, appointed director of the Institute of Toxicology (ITOX) that he chaired from 2003 to 2018. Currently, he is senior professor and group leader at this institute. His research program is aimed at elucidating the mechanisms of DNA repair, DNA damage signaling, mutagenesis, cancer formation, senescence and death of cells exposed to genotoxicants, radiation and anticancer drugs. In his translational research programme, he is especially interested in mechanisms of apoptosis, senescence and resistance of glioblastoma and other cancer cells to alkylating drugs and the repair of critical DNA lesions. He also studied the mechanism and benefit of TCM drugs such as artesunate and curcumin. He is author of more than 400 scientific publications and book chapters and serves as editorial board member and reviewer for many scientific journals. Statistics: PubMed 320 listed papers, HI: 79. Listed in https://expertscape.com/ex/dna+repair top 30 among 89,376 scientists in the field of DNA repair.

Member of the Board of Directors of the Turkish Society of Medical Oncology

Chief Physician, Professor and Doctoral Supervisor of Three Gorges Hospital, Chongqing University

Director of the Medical Pathology Center, Clinical Research Center, Early Diagnosis and Treatment Center for Tumors and Translational Medicine Research Center

Director of the Middle Line (NUT) Cancer Specialty

Clinical Focus: Early diagnosis and standardized treatment of tumors, including the establishment of the first national NUT midline carcinoma specialty and the creation of an integrated diagnosis and treatment platform for this disease. Research Focus: Anti-tumor clinical drug development and translational research; research on tumor immune regulation mechanisms; research on the synergistic mechanism of tumor epigenetics and immunity. Currently Responsible Projects: Obtained 5 clinical approval documents for national 1.1 class new drugs; led the formulation of 1 national expert consensus and participated in the formulation of 1 consensus; won the first prize of the China Industry-University-Research Cooperation Innovation Award (individual), the first prize of the China Invention Association's Entrepreneurship and Innovation Award (1/6), the first prize of the Ministry of Education's Scientific and Technological Progress Award (6/16), and the second prize of the provincial and ministerial scientific and technological progress award (6/8); applied for over 20 national invention patents and software copyrights, with 5 authorized; published over 110 SCI papers, including over 50 as first or corresponding author; research results published in Nature, Advanced Science, Science Translational Medicine, JCI, J Hepatol, Circulation Research, Nature Communication, etc.; led 1 sub-project of the National Key Research and Development Program and 2 National Natural Science Foundation of China general projects. Main Academic Appointments: President of the Digital Healthcare Committee of the China Food and Drug Safety Enterprise Quality Promotion Association (FDSA), Vice Chairman of the Integrated Lung Cancer Prevention and Screening Committee of the China Anti-Cancer Association, Chairman of the NUT Midline Carcinoma Gene Diagnosis Working Group of the Gene Diagnosis Committee of the China Anti-Cancer Association, Vice President of the Overseas Chinese Association of Science and Technology and the Liaison Officer of Chongqing.

Chief Physician of the Department of Hematology, Henan Cancer Hospital
National Committee Member of the Hemostasis and Thrombosis Group of the Chinese Medical Association
National Committee Member of the Hematology Branch of the Chinese Geriatrics Society
Member of the International Society of Hemostasis and Thrombosis (ISTH)
Standing Committee Member of the Tumor Critical Care Professional Committee of the Henan Anti-Cancer Association
Vice Chairman of the Thromboembolism Branch of the Henan Microcirculation Society

Associate Professor of Eskişehir Osmangazi University, Faculty of Medicine, Department of Internal Medicine

 Associate Professor, Trakya University Faculty of Medicine, Department of Internal Medicine

Associate Professor of periodontology and oral medicine at the School of Dentistry, University of Catania, Italy. 
Member of the Italian Society of Oral Surgery (SIdCO)
Member of the International Association of Dental Research (IADR) 
Member of the Italian Society of Periodontology (SIdP)

Researcher, Adipose Stem Cell and Fat Metabolism Research Group, Guangdong Key Laboratory of Stem Cell and Regenerative Medicine
Research Group Leader, Key Laboratory of Regenerative Biology, Chinese Academy of Sciences

Director and Professor, Zhengzhou University, China

Recipient of the State Council Special Allowance, China
Academic Vice President, Medical School, Zhengzhou University
Chief Scientist, The First Affiliated Hospital of Zhengzhou University
Director, Biotherapy Center and Division of Bioimmunotherapy, The First Affiliated Hospital of Zhengzhou University
Member, European Society of Immunology (ESI); American Association for Cancer Research (AACR); American Association of Immunologists (AAI)
Council Member, Chinese Society of Immunology
Chair, Professional Committee on Biotherapy, Henan Anti-Cancer Association & Henan Society of Immunology
Executive Vice Chair, Cell Therapy Quality Management and Research Branch, China Quality Management Association for Pharmaceuticals
Vice Chair, Biotherapy Branch, Chinese Society of Research Hospitals
Standing Council Member, Committee on Tumor Immunotherapy, Chinese Anti-Cancer Association (CACA)
Committee Member, Immuno-Oncology Committee, Chinese Society of Clinical Oncology (CSCO)

Professor of Obstetrics, Gynecology, Endoscopic Surgery and Reproductive Medicine, Ain Shams University, Cairo, Egypt.

Consultant of Obstetrics, Gynecology and Endoscopic Surgery, Ahmadi Hospital, Kuwait Oil Company (KOC), Kuwait.

Visiting Professor in West Kazakhstan Medical University, Aktobe, Kazakhstan since 2018-2019.

Certified Publons Academy Mentor, Supervisor and Reviewer

Editorial Board Member of the BMC Series (BMC Women`s Health)

Editorial Board Member of the Gynecology, Obstetrics, Reproductive Medicine (GORM-Turkey).

Member of the European Society of Human Reproduction and Embryology (ESHRE)-E-13-00010.

Professor of Radiology and the Managing Director of the Nuclear Diagnostic Imaging Centre at Universiti Putra Malaysia (UPM)

Dr Akhter is working as Assistant Professor-I in School of Pharmaceutical and Population Health Informatics (SoPPHI), DIT University, Dehradun, India since 09 October 2017. He has graduated and Master in Pharmacy (Pharmaceutics) from Jamia Hamdard, New Delhi and completed doctoral program in 2016. He had qualified GATE Exam conducted by IIT, Kanpur, Govt of India, percentile score 97.04 in 2007. He had honoured with JRF by UGC Govt. of India, SRF by DST-SERB Govt of India. His work of interest is novel drug delivery system, nanomedicine, nanotechnology-based formulation design, engineering nanoparticles, their surface functionalization for various target diseases including cancer treatment, and development of animal model/xenograft model. He has published >65 research and review papers in high impact journal of repute, 05 book chapters, 07 patents published and 03 Granted, and peer reviewed >50 articles. His present cumulative impact factor is >150 and H-index is 21, Google citation is 1107, Publon-Web of Science citation (755). He has attended and presented many papers at national and international conferences/seminars/symposia. He is an editorial board member of Eur J Med and Oncology (JCR Clarivate IF-2.5). He has been awarded with the research excellence award for the consecutive years 2019, and 2020, and 2021, and 2022 in DIT University.

Dr. Georgios Alexiou is an Associate Professor of Neurosurgery at the University Hospital of Ioannina, Greece since 2017. He undertook his neurosurgical training at ‘’Agia Sofia’’ Children’s Hospital in Athens, Greece and at the University Hospital of Ioannina, Greece. After finishing his residency, he received the EANS Spine Fellowship award and worked as a Clinical Fellow in the Department of Neurosurgery in Leeds Teaching Hospital, UK. He then received the AANS International Travelling Fellowship in Pediatric Neurosurgery award at the Department of Pediatric Neurosurgery in Boston Children's Hospital, Harvard Medical School. Dr. Alexiou worked as a consultant at the Gamma Knife Center at the University Hospital La Timone in Marseille, France. He has a Master degree in Biotechnology and Public Health. His PhD thesis was on the differential diagnosis of glioma recurrence from radiation necrosis using SPECT and MRI and resulted in a clinical study that was funded by the Horizon 2020 program of the European Commission (5M Euro). Dr. Alexiou worked as a postdoctoral research fellow at MD Anderson Cancer Center in Houston Texas and is currently working also on basic research at the Neurosurgical Institute in Ioannina, Greece. He has authored more than 290 international publications in the field, one academic book, edited one book and he is in the editorial board of several International Journals. His primary research interests are intraoperative flow cytometry for brain tumor surgery, pediatric neurosurgery, advanced imaging and radiotherapy techniques for gliomas and on the discovery and validation of novel plant derived compounds for glioma treatment.

He have many years of experience as anesthesia / intensive care nurse, medical laboratory technologist, biologist and teacher with many years of experiences in clinic. He have expanded my knowledge and experience by achieving PhD in molecular and cell biology. His teaching fields include anatomy, physiology, pharmacology and pathology.

He was born on January 14, 1953 in Kahramanmaraş. He graduated from Kahramanmaraş High School in 1970 and Ankara University Faculty of Medicine in 1976 with first degree. He became Internal Medicine Specialist at the same faculty in 1981. In the same year, he worked on genetic manipulations at the University of Louis Pasteur in Strasbourg. He became Associate Professor in 1987, Medical Oncology Specialist at Istanbul University Oncology Institute in 1991 and Professor in 1995. He is a member of ASCO and certified ESMO. In March 2017, he left the Istanbul University Oncology Institute, where he worked for 29 years, and started to work in Istinye University Faculty of Medicine Bahçeşehir Liv Hospital. He served as a member of the Board of Medical Oncology Association and Oncology Group Association - Turkish Oncology Group. He is married with one child and has 121 publications in Turkish, English and French in various medical books and journals, and 109 papers presented at national and international congresses. 41 of his publications have been published in PubMed indexed journals. His publications have been cited in 3492 by February 2020 and his H-index: 16, i10-index: 22 (Source: www.googlescholar.com). His principal clinical research interests have been in gastrointestinal cancers. He has participated to some international studies such as PETACC-1, CPT-CMA 202, Aventis V-306, V-307, CRYSTAL, RADIANT-2, CORRECT, RILOMET, REGARD and MODUL. His another area of interest is theoretical biology, especially intercellular communication. He is in the editorial board of the World Journal of Gastrointestinal Oncology (2018), Turkish Journal of Cancer (2003) and Acta Oncologica (Turkish Edition) (2004). Prof. N. Faruk Aykan speaks English and French.

Dr. Gülcan Bulut completed her medical studies in 2012 from theSpecialization in Medicine-Ege University Faculty of Medicine-Internal Medicine and further went on to get a specialization degree in 2016 From Minor Specialization-Ege University Faculty of

She started her career in 2007 from Research Assistant-Ege University Faculty of Medicine, Department of Internal Medicine and currently she is working  at the renowned Medicana International İzmir Hastanesiin.

She is known for providing stellar treatment for multiple diseases and disorders, including   Targeted therapy, Immunotherapy, Chemotherapy, Personalized treatment in cancer.

She has over 14  years of experience as an Oncologist and has particularly made a name for herself when it comes to Medical Oncology.

She has primarily worked with five hospitals during her tenure and has cured multiple patients with different types of procedures.

Febrile Neutropenia Association

Medical Oncology Group

Internal Medicine Association

Society of Medical Oncology

Ankara Medical Oncology Association

Dr. Desrosiers is currently Professor of Pathology at the University of Miami Miller School of Medicine. Before moving to Miami eight years ago, he was tenured Professor of Microbiology at Harvard Medical School and served as Director of Harvard’s Primate Research Center. His laboratory is credited with the discovery of the monkey virus called SIV (simian Immunodeficiency virus) that is the close monkey relative of the human AIDS virus; and the discovery of the monkey virus that is a close relative of the human Kaposi sarcoma herpesvirus. His research has contributed importantly to the understanding of viral pathogenesis and to vaccine development efforts. He currently lists more than 340 refereed publications on his CV.

Dr. Cao is currently appointed as an Associate Professor in the Department of Oral and Maxillofacial-Head and Neck Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine; College of Stomatology Shanghai Jiao Tong University (since 2017). Previously, Dr. Cao was a visiting student at the University of Maryland School of Dentistry, Maryland (2009-2010). After back to China, Dr. Cao received his MD and PhD from Shanghai Jiao Tong University (2011). His training fellowship of Head & Neck Oncology was completed from Shanghai Ninth People's Hospital (2011-2015). Dr. Cao is a member of the American Association for Cancer Research (AACR) as well as a member of American Society of Gene and Cell Therapy (ASGCT). He joined the Editorial Board and was appointed as the Guest Associate Editor for "Frontiers in Oncology (IF:6.244)" in January 2020. He also was appointed as an Associate Editor for Technology in Cancer Research & Treatment (IF: 3.399) in Feb.2022. He joined the Editorial Board Member of BMC Cancer (IF:4.46) as well as Oncology letters (IF: 2.967) as well as Associate Editorial Board Member of " Cancer Biology & Medicine (IF:4.248)" from December 2021.Up till now, he has published 56 articles (total times cited 1058, H-index 19) including, "Molecular Cancer, EMBO Journal, Theranostics, Molecular Therapy-Nucleic Acids, Bioinformatics, Cancer, Cancer Prevention Research, Oral Oncology, Head & Neck". He hosted 3 projects from the Natural Science Foundation of China. His research interest includes Head Neck Oncology, Epigenetic modification, Classifier for early detection, predict lymph node metastasis and survival based on transcriptome.

Full Professor of Gynecology and Obstetrics, SC 06/H1, SSD MED/40

Head of the Gynecology Unit, Sant'Andrea University Hospital

Head of the Department of Obstetrics, Gynecological, and Pediatric Sciences, Sant'Andrea University Hospital

Director of the School of Specialization in Gynecology and Obstetrics, Sapienza University of Rome

Coordinator of the PhD Program in Translational Medicine and Oncology, Sapienza University of Rome

Long-Sheng Chang, PhD, received his bachelor's degree from National Taiwan University and his doctoral degree from Rutgers University-New Jersey Medical School. Subsequently, he did a postdoctoral training at Princeton University. In June 1990, Dr. Chang joined the faculty at the Abigail Wexner Research Institute at Nationwide Children’s Hospital and The Ohio State University (OSU) College of Medicine. Currently he is a principal investigator in the Center for Childhood Cancer and a Professor in the OSU Department of Pediatrics. Also, he has adjunct appointment to the Departments of Biological Chemistry & Pharmacology, Otolaryngology, Pathology, and Veterinary Bioscience, Molecular Cellular & Developmental Biology (MCDB) Program, Ohio State Biochemistry Program (OSBP), and Biomedical Sciences Graduate Program (BSGP).

Prof. Xiaojun Chen is with Institute of Biomedical Manufacturing, School of Mechanical Engineering, Shanghai Jiao Tong University (SJTU), China. He received his Ph.D from SJTU in 2006, and then furthered his research as a postdoctoral fellow at the same institution until 2008. After that, he has been working at SJTU as assistant professor (2008-2010), associate professor (2010-2018), full professor(2018-2025), and tenured full professor(2025-now). His research focuses on biomedical image analysis, image-guided interventions, artificial intelligence in biomedical physics and analysis, VR/AR/MR technology in medicine, medical robotics, biomedical manufacturing, etc. As a visiting professor, he had worked at the Surgical Planning Laboratory, Harvard Medical School during Oct 2011~ Oct 2012; the TIMC-IMAG lab, CNRS, France during Sep~Dec 2013; the OMFS-IMPATH lab, KU Leuven, Belgium during Jun~Aug 2015, and the CISTIB lab, the University of Sheffield, UK during Jun~ Aug 2016.
He is the author and co-author of more than 200 peer-reviewed journal/conference articles in MedIA, IEEE-TMI, IEEE-TBME, IEEE-TVCG, CMIG, CMPB, IJCARS, etc., the owner of more than 30 patents, and have delivered more than 50 lectures in the prestigious international conferences including IEEE-EMBC, IEEE-ITAB, MICCAI, CARS, iSMIT, CAI, etc. He was granted Second Prize of National Science & Technology Progress Award of China (2019), Chinese Society of Stomatology Science and Technology Award (2018), Jiangsu Province Science & Technology Award (2017), China Medical Science and Technology Award (2016), Shanghai Science & Technology Award (2010), Shanghai Medical Science & Technology Award (2008).

President Chen obtained PhD in 1999 at Kaohsiung Medical University. Currently teaches in Fooyin University, as most young is also the most senior professors and deans. The past 20 years, he has his scientific interests focused on life-threatening diseases, including traditional Chinese medicine used for cancer research. Analysis in recent year’s major active ingredients such as ginger, pepper and cinnamon used in gastrointestinal cancer, anti-inflammatory, antioxidant, antiparasitic, and other topics. President Chen specializes in isolation, purification and structural analysis of active components of plants. President Chen directed against active constituents of oral cancer, liver cancer, and rectal cancer. He specialized in Taiwan study on the plants of the genus cinnamomum. Several keyword searches, such as: Cinnamomum, ranking first in the world. President Chen was just over 45 years old, but his work has more than 200 papers, Taiwan one of the young talents. Professor Chen was invited more than 40 kinds of Journal editorial boards. Professor Chen won numerous awards at home and abroad, from 2015, was awarded the lifetime achievement award.

Dr. William Cho is a biomedical scientist at the Department of Clinical Oncology, Queen Elizabeth Hospital in Hong Kong. With a strong background in cancer biomarker discovery and translational research, Dr. Cho has published extensively in peer-reviewed journals. His research interests include genomics, proteomics, and liquid biopsy in oncology. He actively serves on editorial boards and is a frequent reviewer for international scientific journals.

Prof. Ugo Cioffi is a Professor in the Department of Surgery University of Milan, Milano, Italy. Prof. Cioffi obtained his M.D degree from the University of Naples, Italy, in 1981, specilization in General Surgery, and his Ph.D. degree in medicine from the University of Milan. He worked as a Researcher at IRCCS Ospedale Maggiore Policlinico, University of Milan, since 1989. From 2005 he was a Contract Professor at the University of Milan. Since 2012 he has been working as a Professor of surgery. He was awarded with ATLAS OF SCIENCE in 2016, 2017, 2018 and The International Biographical Centre Cambridge “International biographical association award in 2014. Awarded with Ambrogino d'Oro from Comune di Milano in 2014. Prof. Ugo Cioffi's research interests include Esophageal, Mediastinal, Lung surgery and Video-Assisted Thoracoscopic Surgery.

Roberto Cuomo currently works at the Department of Medicine, Surgery and Neuroscience, University of Siena as Assistant Professor. Roberto does research in Plastic Surgery in the field of wound care, breast surgery, breast cancer, body contouring, obesity and post-obesity surgery, local-flaps reconstruction, aesthetic, non-melanoma and melanoma skin cancer, rare skin cancer.

Full Professor of General Surgery at the Department of Surgical Sciences at Sapienza University of Rome.
Dean of the Full Professors of General Surgery at the Faculty of Medicine and Dentistry at Sapienza University of Rome.
Commissioner of Sapienza PhD Programs for the three Faculties of Medicine.
Director of the Department of Surgical Sciences at Sapienza for the academic three-year period 2019-2022.
Deputy Director and first elected Full Professor to the Board of the Department of Surgery at Sapienza for the three-year period 2022-2025.
2006 Gold Medal of the Italian Republic for Merit in Public Health.
Coordinator of the PhD Program in "Advanced Technologies in Surgery" at Sapienza University of Rome from July 1, 2014 to February 12, 2021.
"Alternate Italian Representative" in the Horizon Europe CANCER Mission
Institutional Representative of Sapienza for the EUA (European University Association) Network and CDE (Council for Doctoral Education) from March 31, 2021 to present.
Representative of Macroarea C on the Technical-Scientific Committee of the Sapienza Library System.
President of the Degree Course in Occupational Therapy B at Sapienza – Viterbo Campus – from October 5, 2016 to October 31, 2019.
Special Commissioner of the Degree Course in "Occupational Therapy B" at Sapienza University – Viterbo campus – from October 23, 2013 to September 23, 2014 and from February 16, 2016 to October 5, 2016 (from October 5, 2016 to the present, he has been President of the Degree Course).
Deputy Director of the Department of Surgical Sciences at Sapienza University of Rome for the two academic years 2011-12 and 2012-13.
"Sapienza Evaluator" and member of the Sapienza Research Scientific Committee from June 27, 2011 to the present.
U-GOV Research Coordinator for the Department of Surgical Sciences at Sapienza University from the 2010-11 to the 2014-15 academic year.
IRIS coordinator for the Department of Surgical Sciences at Sapienza University since the 2015-16 academic year.
Associate Professor of General Surgery, serving from February 2, 2000 to January 3, 2018, at the Department of Surgical Sciences at Sapienza University.
He discovered and described angiomegaly, a disease of the arteries and veins, renamed by a group of Sapienza professors after the author, "D'Andrea's Disease," J.B.R.H.A., 31(2): 473-479, 2017.
He invented the first bioclimate control system for the transport of organs for therapeutic transplants
(Patent No. 228312 issued on February 18, 1998 by the Ministry of Industry).
He invented the "electro-optical surgical forceps for the automatic recognition of nerves, arteries, and veins during surgical procedures" (Patent approved by Sapienza University, filed on August 18, 2015, registered by the Ministry of Economic Development on February 7, 2018, U.0057778.07-02-2018).
He is Head of the "Technological Innovations in General Surgery" Program at the Umberto I Hospital in Rome.
He has been Director of the Complex Program "Diagnostic-Therapeutic Pathways in Oncological Surgery" SCHP 01 at the Umberto I Hospital in Rome from April 2, 2020 to the present.
Clinical Consultant Surgeon for the Carabinieri.
Actual Member of the Medical Board of the Senate of the Republic in the 15th Legislature.
Founding President of the College of Associate Professors of General Surgery.
Councilor of the Rome Section of the Italian Catholic Doctors Association.
Secretary of the I.S.A., Italian Scientists Association,
Secretary of the S.I.R.C., Italian Society for Research in Surgery

Olga D. Savvidou is an Associate Professor of Orthopaedics at the First Department of Orthopaedic Surgery, School of Medicine, National and Kapodistrian University of Athens, Greece. She received her MD from Aristotle University of Thessaloniki in 1990 and completed her Residency in Orthopedic Surgery at the General Hospital of Veria from 1994 to 1995, and at the General Hospital “G. Genimatas” from 1995 to 1997. She also completed a Residency in Orthopedic Surgery at “Hippokration” General Hospital from 1997 to 2000. In 2001, she earned a PhD from Aristotle University of Thessaloniki. Dr. Savvidou has completed several fellowships, including at the Royal National Orthopaedic Hospital, London, UK from 1998 to 1999, Pulvertaft Hand Centre, Derby, UK in 2000, Nuffield Orthopaedic Hospital in 2000, and “KAT” Hospital in 2001. She is a member of several medical associations, including Athens Medical Association, Athens, Hellenic Medical Association, Hellenic Association of Orthopaedic Surgery and Traumatology (HAOST), College of Hellenic Association of Orthopaedic Surgeons, Hellenic Society for Reconstructive Microsurgery, Hellenic Society for Surgery of the Hand, British medical Council, UK, and International Affiliate Member American Academy of Orthopaedic Surgeon.

Assistant Professor (Researcher type B) in Obstetrics and Gynecology, Unit of Gynecologic Oncology, ARNAS "Civico – Di Cristina – Benfratelli", Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo (Palermo, Italy).
Antonio Simone Laganà was born in Reggio Calabria (Italy) on 8th May 1986. He is Deputy of the Special Interest Group for Endometriosis & Endometrial Disorders (SIGEED) of the European Society of Human Reproduction and Embryology (ESHRE) and Ambassador of the World Endometriosis Society (WES).
Antonio Simone Laganà was trained in obstetric/gynecological ultrasound at the Altamedica Main Centre in Rome (Italy), got the Master in “Gynecological Minimally Invasive and Robotic Surgery” at the University of Pisa (Italy), the Ph.D. in “Medical and Surgical Biotechnologies” at the University of Messina (Italy), and developed an intensive training in minimally invasive gynecological surgery (high-volume advanced laparoscopy, hysteroscopy) at the Univerzitetni Klinični Center Ljubljana (Slovenia), during the Subspecialist Training Programme (Fellowship) in Reproductive Medicine (according to the criteria of the European Society of Human Reproduction, ESHRE, and Embryology and European Board & College of Gynecology and Obstetrics, EBCOG).
His research interests include endometriosis, reproductive immunology, infertility, gynaecological endocrinology, laparoscopy, and hysteroscopy. He is the author of more than 300 papers published in PubMed-indexed international peer-reviewed journals, and his presence is often requested as an invited speaker at international congresses. He is currently an editor of high-impact journals, including Scientific Reports, PLOS One, Journal of Minimally Invasive Gynecology, Journal of Ovarian Research, Gynecologic and Obstetric Investigation, and many others.
He is habilitated as Associate Professor in Italy for Gynecology and Obstetrics.

Dr. Meran Keshawa Ediriweera is a lecturer in Biochemistry and Molecular Biology at the Department of Biochemistry & Molecular Biology, Faculty of Medicine, University of Colombo, Sri Lanka. He was educated at the Richmond College, Galle (1991-2005). Following completion of the undergraduate degree in India (2006-2009), he joined the Institute of Biochemistry, Molecular Biology and Biotechnology (IBMBB), University of Colombo for his Master degree in Molecular Life Sciences (2010-2012). He was awarded his PhD in Molecular Biology and Medicinal Chemistry from the IBMBB in 2017. Upon completion of his PhD, Dr. Ediriweera worked as a Postdoctoral researcher at the IBMBB for almost two years. In 2019, he moved to South Korea for another Postdoctoral fellowship where he worked at the Functional Genomic Biochemistry laboratory of the Subtropical/Tropical Organism Gene Bank, Jeju National University.

Academic Member of the Department of Hematology at İnönü University Turgut Özal Medical Center (TÖTM)

Ministry of Health Therapeutic Apheresis Scientific Advisory Committee Member

Head of the Department of Immunohematology at İnönü University Health Sciences Institute

Director of the TÖTM Bone Marrow Transplantation Unit

Head of the TÖTM Tissue Typing Laboratory

Head of the TÖTM Therapeutic Apheresis Unit

President of the Transplantation and Cellular Therapies Association

2016 - Present Prof. Dr.
İnönü University, Faculty of Medicine

2011 - 2016 Assoc. Prof. Dr.
İnönü University, Faculty of Medicine, Department of Internal Medicine

2009 - 2011 Assoc. Prof. Dr.
İnönü University, Faculty of Medicine, Department of Internal Medicine

Dr. Alfio Ferlito is Formerly Director of the Department of Surgical Sciences at the University of Udine School of Medicine from 2003 to 2009 and Professor and Chairman of the ENT Clinic at the same University from 1997 to 2013. He graduated in medicine at the University of Bologna in 1968. He completed his residency programme in Otolaryngology and subsequently in pathology. He worked at the ENT Department of Padua University from 1970 to 1997. Since 2009 he is the Coordinator of the International Head Neck Scientific Group.

Dr. Alfio Ferlito received many honors and awards during his career.  He served as editor, co-editor, assistant editor or reviewer for the 736 journals. He has collaborated in writing articles, editorials, commentaries, letters to the editor, special issues, book chapters and books with 665 international experts. He has edited a three-volume book entitled Cancer of the Larynx (CRC Press, Boca Raton, 1985) and three other books entitled Neoplasms of the Larynx (Churchill Livingstone, Edinburgh, 1993), etc. He is Editor of four issues of ORL Journal for Oto-Rhino-Laryngology, Head and Neck Surgery. He has been author and co-author of 657 referred publications in 70 medical journals and 54 chapters in various books. He is a fellow or a member of the many societies. He collaborated as a member of the World Health Organization’s Committee on Histological Typing of Tumors of the Upper Respiratory Tract and Ear. He is also a member of the Laryngeal Cancer Association’s Committee on the Classification of Laryngeal Cancer. He was a consultant to Yale University. He was a consultant to Yale University. He has delivered prestigious lectures all over the world. In 2006 he gave the 2nd Morrison Lecture in San Francisco and the 19th Som Lecture in New York. He has divided his professional life between clinical practice, teaching and research.

Pedro Fonte is Assistant Professor at the Faculty of Sciences and Technology, University of Algarve, Portugal. He is also an integrated member at Center of Marine Sciences (CCMAR), University of Algarve, Portugal and collaborator researcher at the Institute for Bioengineering and Biosciences, Instituto Superior Técnico, University of Lisbon, Portugal. He graduated in Pharmaceutical Sciences in 2010 and obtained his PhD in Pharmaceutical Sciences – Nanotechnologies specialty at the Faculty of Pharmacy, University of Porto, Portugal in collaboration with the University of Copenhagen, Denmark, in 2016. He also obtained a Master of Business Administration (MBA) at the Faculty of Economics and Business Management, Lusíada University, Portugal in 2012. His area of scientific activity is on the development of new drug delivery systems by means of colloidal carriers, structural characterization of proteins entrapped into micro- and nanocarriers, lyophilization of biopharmaceuticals, targeted and controlled delivery of drugs across biological barriers, solid state characterization of pharmaceuticals and drying of pharmaceuticals and biopharmaceuticals. He is also conducting research in the regenerative medicine field, focusing in wound healing, tissue regeneration and cell therapy. In his activity he is enrolled in the up-scale of pharmaceutical products and is involved in entrepreneurship activities.

Dr. Francesco Izzo received his medical degree from the University of Naples, Federico II Medical School, Italy. He completed a general surgery residency at the University of Naples, Italy and then completed a fellowship in Surgical Oncology at the University of Texas Anderson Cancer Center. Dr. Izzo has been on the faculty in the Department of Surgical Oncology at the National Cancer Institute of Naples, Italy since completing his fellowship. He is now Full Professor of Surgery, Director and Coordinator of the Abdominal and Hepatobiliary Surgical Oncology Division and Chief of Liver Tumor Study Group at the National Cancer Institute of Naples, Italy.
Dr. Izzo’s clinical practice and research focuses on surgical oncology new treatments particularly for patients with Hepatobiliary and pancreatic tumors.
Dr. Izzo has been a pioneer in designing new treatments for patients with liver tumors, including radiofrequency ablation, improved techniques for surgical removal of liver cancers, and several types of direct tumor injection therapy.
Dr Izzo is principal investigator on a number of National and International protocols for the basic science and clinical treatment on primary and metastatic hepato-biliary cancers.

Li-wu Fu, Ph.D., Professor, Doctoral Supervisor. Prof. Fu obtained his PhD in the field of Cancer Pharmacology from the Sun Yat-sen University and carried out his doctoral research in South Carolina Medical University from 1999 to 2001.

Prof. Fu’s field of expertise includes anticancer drug pharmacology, molecular mechanism of anticancer drugs and individual cancer chemotherapy. In recent years, he mainly focused on the study of molecular mechanism of anti-cancer drugs, drug resistance of cancer cells (especially multidrug resistance), the innate resistance of cancer stem cells and the individual cancer chemotherapy. For the excellent work in the research of “Strategies for overcoming ABC-transporters-mediated multidrug resistance (MDR) of tumor cells”, Prof. Fu’s team gained the first prize of “Chinese Anti-Cancer Association (CACA) Science and Technology Award” (Ranked first) and the second prize of “Institute of Higher Education Outstanding Scientific Research Achievements Award” (Natural Science Award) in 2011.

As the leader of the research group, he has won the provincial and ministerial level scientific and technological awards for several times, including the “Outstanding young scientific and technological talents award from Ministry of Health”, the “Servier outstanding young workers Pharmacology Award” and the “Ding Ying Science Award” in 2011.

Prof. Fu has presided over and successfully completed more than 40 key research projects on national, provincial and ministerial scale and horizontal fund projects.

More than 200 research papers have been published and up to 100 papers have been published in high-quality SCI journals, including Cancer Res (6 articles), Oncotarget, Mol Med, Cell Cycle, Eur J Cancer, Mol Cancer Ther, Birth J Parmacol, Biochem Pharmacol , Mol Pharmacol etc. and 10 invention patents have been attained.

 Professor Vittorio Gebbia, MD, PhD, is a board certified medial oncology and hematology oncologist specializing in the treatment of a variety of adult cancers with medical therapy. He obtained his M.D. and Ph.D. cum laude from the University of Palermo, Italy in 1983 and 1989 respectively. He finished his PhD oncology/hematology training at the Johns Hopkins Oncology center, Baltimore, USA in 1987. Professor Gebbia is a published expert on the diagnosis and treatment of solid tumors with a particular focus in gastrointestinal and thoracic malignances. He has expertise and published a number of papers on the treatment of pancreatic, colon and lung cancer as well as combined modality treatment and supportive care. He has given several talks in national and international meetings on his work. He is on several Editorial Boards related to cancer and cancer treatment. He is a member of American Society of Medical Oncology (ASCO) and a board-certified member of the European Society of Medical Oncology (ERSMO) as well as the Italian Society of Medical Oncology. He has been Assistant Professor of Medical Oncology at the
 University of Palermo since 1999 and at present is Associate Professor of Medical Oncology at the same place. He is interested in arts and is a collector of antique prints.

Anar Gojayev currently works at the Biology Education, Qafqaz University. Their most recent publication is 'Evaluation of toxic effects of synthesized carbon nanotubes on levels of cytochrome p-450 and serotonin-modulating anticonsolidation protein in liver of mice'.

Simona Gurzu is MD (2008) and Habilitated Doctor (2013), Consultant Gastrointestinal Pathologist and Professor at the “George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu-Mures, Romania”, Dean of Faculty of Medicine in English, Head of Pathology Department, and CEO of Clinical Department of Pathology were she founded a Research Center of Oncopathology and Translational Medicine (CCOMT) and a Digitalized Center of Morphological Sciences, Member in the Scientific Council of PhD School, Member in the Roamnian Academy of Medical Sciences, Invited Associated Professor at Hamamatsu University, Japan, and Invited Researcher at the National Institute of Oncology, Budapest, Hungary, and Seoul University, South Korea. Alumni of UNESCO-L’Oreal programme “For women in science” and of “ASPEN”. Teaching and research activity in histological, immunohistochemical, and molecular aspects of tumor and non-tumor lesions.

Doctor of Oncology, researcher, supervisor of master's and doctoral students, and co-supervisor of postdoctoral fellows. Graduated from the Affiliated Cancer Hospital of Fudan University in June 2013. From June 2013 to September 2015, he conducted postdoctoral research at the Cancer Center of Sun Yat-sen University. Since September 2015, he has been conducting molecular epidemiological research on pediatric cancers at the Guangzhou Women and Children's Medical Center. His main research interests include genetic variation, genetic susceptibility to cancer, and prognosis.

His research focuses are bioinformatics analyses on high-throughput omics data and computational analysis tools development. He have particular interests on genomics studies of hepatocellular carcinoma (HCC) through the application of next generation sequencing, large-scale screening, liquid biopsy, and single-cell and spatial transcriptomics. He is also involved in multidisciplinary and integrative studies to investigate and understand the molecular mechanism of hepatocarcinogenesis, metastasis and treatment response of HCC.

Dr. Jason Chia-Hsun Hsieh, M.D., M.Sc., Ph.D., is a distinguished medical oncologist and professor of medicine at Chang Gung University, National Tsing Hua University (Taiwan) and Chang Gung Memorial Hospital in Taiwan. He specializes in oncology with a strong research focus on circulating tumor cells, liquid biopsy, neuroendocrine tumors, and cancers of the head, neck, liver, and esophagus.

Professor at University of California, Los Angeles, United States.

Dr. Hu is a Professor and was previously the MS Program Advisor in the Division of Oral and Systemic Health Sciences at the UCLA School of Dentistry. He has managed the Oral Biology MS program since 2011. Dr. Hu is also a member of the UCLA Jonsson Comprehensive Cancer Center (JCCC) and currently serving as an editorial board member for multiple international journals. He recently edited the Cancer metabolomics: Methods and Applications for Springer Advances in Experimental Medicine and Biology book series.

Prof. Hannah Xiaoyan HUI obtained her B.Sc. (First Class Honours) in Biotechnology from Shanghai Jiao Tong University and completed her Ph.D. study in Shanghai Institute of Biological Sciences, Chinese Academy of Sciences (SIBS, CAS). She then pursued her postdoctoral training at Department of Medicine, the University of Hong Kong and was later took up her post as Research Assistant Professor at the same department. In 2021, she joined the School of Biomedical Sciences, the Chinese University of Hong Kong as Assistant Professor.

The research interest of Dr. Hui lies solely on Adipose Tissue – a highly plastic organ in our body. We are using genetically engineered mouse models, primary cells/tissues and human iPS-derived adipocytes as model systems. By adopting state-of-the-art, multidisciplinary approaches, the goal of our laboratory is to understand the molecular basis of adipose tissue remodelling and its physiological relevance in obesity and cardio-metabolic diseases. Ultimately we seek to develop biomedicine that can “re-educate” the adipose tissue.

Prof. Hui is the principal investigator of research grants including General Research fund (GRF), Health and Medical Research Fund (HMRF) and NSFC (Young Excellent Scientist). Her research work has been published in top-ranked journals including Cell Metab, J Clin Invest, EMBO rep, Diabetes, Brit J Pharmacol. She also receives awards such as National Science and Technology Progress Award (2020).

Alice Indini is a medical oncologist working at the Fondazione IRCCS Istituto Nazionale dei Tumori in Milan, Italy. She received her medical degree from the University of Milan in 2012, and is board certified as an oncologist physician. Dr. Indini’s main research interests are cutaneous tumors (melanoma, non-melanoma skin cancer), Kaposi’s sarcoma, and immunotherapy. She contributed in creating a multidisciplinary team for the management of patients with skin cancers at the Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, with the long-standing experience of the Dermatology school of the University of Milan. Dr. Indini is an active member of the Italian Melanoma Intergroup (IMI), and takes active part in the development and management of clinical and research activities in the field of melanoma. In 2020, dr. Indini received the approval of the MSD MISP drug-only concept “A Phase II single-arm study of pembrolizumab plus lenvatinib in previously treated Classic Kaposi’s Sarcoma (CKS)”, which she is currently leading as Principal Investigator. She has actively taken part on clinical phase I-III trials of pediatric and adult oncology, as sub-investigator. Dr. Indini has a lively clinical research activity, with production of papers on cutaneous neoplasms, immunotherapy and gynecologic tumors. She is part of the reviewer board of peer-reviewed journal, including the Lancet Oncology and the European Journal of Cancer.

Dr. Ioannidis is an Assistant Professor of Surgery. He studied medicine in the Aristotle University of Thessaloniki and graduated at 2005. He received his MSC in “Medical Research Methodology” in 2008 from Aristotle University of Thessaloniki and in “Surgery of Liver, Biliary Tree and Pancreas” from the Democritus University of Thrace in 2016. He received his PhD degree in 2014 from the Aristotle University of Thessaloniki for his thesis “The effect of combined administration of omega-3 and omega-6 fatty acids in ulcerative colitis. Experimental study in rats.” He is a General Surgeon with special interest in laparoscopic surgery and surgical oncology and also in surgical infections, acute care surgery, nutrition and ERAS. He has received fellowships for EAES, ESSO, EPC, ESCP and ACS and has published more than 130 articles with more than 3000 citations and an H-index of 28.

Dr. Marcello Iriti is an Associate Professor of Plant Biology and Pathology within the Department of Agricultural and Environmental Sciences at the University of Milan.

He has been studying nutraceuticals, functional foods, phytotherapeutics and essential oils relevant for human and animal health, focusing on their preclinical (in vitro/in vivo) and in human pharmacological activities. He has also been investigating the health-promoting effects of traditional Mediterranean diet as well as the ethnopharmacology of herbal remedies of traditional healing systems.

Dr. Iriti is a Member of the World Academy of Sciences, Asian Council of Science Editors and Society of African Journal Editors. Founding Member of the Italian Society of Environmental Medicine. Member of the Working Group ‘Pharmacognosy, Phytotherapy and Nutraceuticals’ of the Italian Pharmacological Society.

Dr. Aasems Jacob is a practicing hematologist-oncologist at Pikeville Medical Center and adjunct faculty at University of Pikeville. He completed medical school from University of Kerala, India and residency in Internal Medicine from Monmouth Medical Center, NJ. He underwent fellowship in Hematology/Oncology at University of Kentucky where he served as the Chief Fellow. His clinical and research interests in the specialty include thoracic oncology, immunotherapy and healthcare disparities.

Jiang Miaomiao, a researcher and doctoral supervisor at Tianjin University of Traditional Chinese Medicine, was selected for the second tier of Tianjin's "131 Plan" and was recognized as an Outstanding Young Scientist and Young Leading Talent in Tianjin's Innovative Talent Promotion Program. Her research focuses on the discovery and mechanism of action of functional polyphenols and polysaccharides in traditional Chinese medicine.

Executive Director of the Center for Frontier Innovation in Medicine, academic doctoral supervisor, and academic master's supervisor. Member of the Standing Committee of the Translational Medicine Committee of the Chinese Microcirculation Association; member of the Integrative Oncology Committee and young member of the Nano-Oncology Committee of the Chinese Anti-Cancer Association; member of the Chinese Society of Neuroscience; correspondence reviewer of the National Natural Science Foundation of China; member of the International Cancer Epigenetics Society; international reviewer of The Brain Tumour Charity Foundation in the UK; international reviewer of post-doc fellowship applications in France.

Abolghasem (Ghasem) Jouyban received his Pharm.D. degree from the Tabriz University of Medical Sciences (TUoMS), Tabriz, Iran, in 1989. He joined the Department of Pharmaceutical Chemistry, TUoMS, in 1991 after having taught for three years at the Faculty of Nursing and Midwifery. He earned his first Ph.D. in Pharmaceutical Analysis from the University of Bradford, the UK, in 2001, and his second Ph.D. in Pharmaceutics from the University of Sydney, Australia, in 2003. Ghasem has more than 810 research papers, an edited Handbook, six book chapters, and two published books in Persian. He received a number of Gold medals from the Razi Research Festival. Ghasem is a member of the Iranian Academy of Medical Sciences, the Iranian Association of Pharmaceutical Scientists, and the Iranian Chemical Society. He is currently the regional editor of Current Pharmaceutical Analysis, Editor of Immunoanalysis, and a member of the editorial board of the Journal of Chemical Thermodynamics, Bioimpacts, and Pharmaceutical Sciences. He is the founder and director of the Pharmaceutical Analysis Research Center at the Tabriz University of Medical Sciences.

Dr. Venkataramana Kandi, Ph.D., MAMS, FAGE, FRCPath, is currently working as an Assistant Professor of Microbiology at Prathima Institute of Medical Sciences, Karimnagar, and affiliated to KNR University of Health Sciences, Warangal. He has done his Masters in Medical Microbiology from Manipal University in India, and after registering for a Ph.D. from Dr. NTR University of Health Sciences, India, he completed his doctoral research on HIV disease management in a highly active antiretroviral therapy era. He has also been awarded a Ph.D. by publication (ASU-America). He has also completed a Ph.D. in clinical research, at the University of Central Nicaragua, Nicaragua. He is conferred with the Fellowship of the Royal College of Pathologists (London, UK). He has more than 20 years of teaching and research experience. He was elected as Member (MAMS) of the National Academy of Medical Sciences (NAMS) for the year 2017. He is a life member of the Indian Association of Medical Microbiologists (IAMM) (LM 1919) and the Association of Microbiologists of India (AMI) (AMI/LM465/3231/2013). He is also a member of the Asian Council for Science Editors (ASCE). He has presented and published nearly 313 research papers at national and international conferences and journals. He received more than 5931 citations for his research papers. His research interests include wide areas of medical microbiology, with a special interest in HIV research, antimicrobials, and infections prevalent in these rural populations.

He Has been Professor for 15 years and Head of Department for about 9 years along with various administrative experiences of KGMU. He has  been Executive Council member of Lucknow University for 2 terms (2010-2013, 2014-2017) and UP Medical University Saifai, Etawah since its inception (2016). National President of all 3 important Chest Societies (Indian Chest Society, National College of Chest Physician (India), Indian College of Allergy, Asthma and Applied Immunology), President of Medical Science Section of Indian Science Congress, president of IMA Lucknow and UP IMA- AMS.

2012 - Present Prof. Dr.
Dokuz Eylül University, Oncology Institute

2005 - 2009 Assoc. Prof. Dr.
Fırat University, Faculty of Medicine, Department of Internal Medicine

Asst prof. Samander Kaushik, completed his PhD in Virology (Microbiology) from the All India Institute of Medical Sciences (AIIMS) in New Delhi, India, in 2010. Since then, he has been working as an assistant professor at Maharshi Dayanand University's Centre for Biotechnology in Rohtak, Haryana, India. His research group is developing rapid, sensitive, specific, and cost-effective diagnostic tests and treatment agents. He has twenty years of expertise in this field and has published more than forty papers in PubMed/Scopus-indexed/peer-reviewed journals, as well as three book chapters with an 820 citation index. He received financial support from a variety of sources for his lab's research efforts.

Full Professor of Advanced Medical and Surgical Technical Sciences, University of Catania, Italy

Consultant Neurologist & Chief, Clinical Neurophysiology Research Unit, Oasi Research Institute‑IRCCS (a WHO Collaborating Centre), Troina, Italy

Assistant Professor (Senior Academic Researcher), University of Catania

Visiting Clinical Research Fellow, Department of Neuroscience & Clinical Neurophysiology, Newcastle University, UK

Scientific Fellow selected by the European Federation of Neurological Societies (EFNS), 2013

International award for translational research in sleep medicine

Dr. John Spiliotis is a distinguished surgical oncologist affiliated with both the European Interbalkan Medical Center in Thessaloniki and Athens Medical Center in Athens, Greece. He has extensive clinical experience in oncology surgery and has contributed significantly to cancer treatment strategies, particularly in gastrointestinal and hepatobiliary cancers. Dr. Spiliotis is actively involved in academic research and has published widely in international medical journals.

• Musculoskeletal biomechanics and stem cell fate regulation

• Osteoarthritis pathogenesis and cartilage/meniscus repair

• Biomaterials and translational strategies in joint disease